Maykin Ho

Insider profile

Currently holds positions in Agios Pharmaceuticals, Inc., PAREXEL International Corp and Kyntra Bio, Inc.

Positions

Position Company Period
Independent Director Agios Pharmaceuticals, Inc. June 23, 2015 -
Independent Director PAREXEL International Corp Aug. 26, 2015 -
Independent Director Kyntra Bio, Inc. Dec. 6, 2018 -
Maykin Ho's trades of Kyntra Bio, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
324.43
Quantity 56,077 +24.7%
Value US$2,185,847
Transaction date
Planned sale
Price
353.12
Quantity 22,492 +39.8%
Value US$3,800,316
Transaction date
Proposed sale
Price
291.06
Quantity 1,502
Value US$1,545,822
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-09 2023-06-08
PlS Planned sale
56,077 +24.7%
324.43
US$2,185,847 		56,077 +24.7% 324.43 US$2,185,847
2023-06-09 2023-06-08
PlS Planned sale
22,492 +39.8%
353.12
US$3,800,316 		22,492 +39.8% 353.12 US$3,800,316
2023-06-08 2023-06-08
PrS Proposed sale
1,502
291.06
US$1,545,822 		1,502 291.06 US$1,545,822